Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$53.86 - $66.8 $18,473 - $22,912
343 Added 9.31%
4,029 $218,000
Q2 2022

Aug 03, 2022

SELL
$63.83 - $80.0 $10,531 - $13,200
-165 Reduced 4.28%
3,686 $237,000
Q1 2022

May 04, 2022

SELL
$76.85 - $89.45 $80,769 - $94,011
-1,051 Reduced 21.44%
3,851 $299,000
Q4 2021

Feb 02, 2022

BUY
$74.57 - $87.19 $149 - $174
2 Added 0.04%
4,902 $422,000
Q3 2021

Nov 02, 2021

BUY
$73.77 - $83.61 $30,540 - $34,614
414 Added 9.23%
4,900 $395,000
Q2 2021

Aug 06, 2021

SELL
$80.5 - $88.01 $161 - $176
-2 Reduced 0.04%
4,486 $362,000
Q1 2021

May 11, 2021

BUY
$76.38 - $86.03 $67,367 - $75,878
882 Added 24.46%
4,488 $379,000
Q4 2020

Feb 12, 2021

SELL
$75.39 - $82.36 $21,787 - $23,802
-289 Reduced 7.42%
3,606 $290,000
Q3 2020

Nov 13, 2020

BUY
$78.33 - $90.73 $30,470 - $35,293
389 Added 11.1%
3,895 $314,000
Q2 2020

Aug 11, 2020

BUY
$78.66 - $94.14 $6,922 - $8,284
88 Added 2.57%
3,506 $302,000
Q4 2019

Feb 07, 2020

BUY
$76.7 - $88.45 $6,903 - $7,960
90 Added 2.7%
3,418 $286,000
Q3 2019

Nov 06, 2019

SELL
$81.4 - $89.78 $7,326 - $8,080
-90 Reduced 2.63%
3,328 $291,000
Q2 2019

Jul 31, 2019

SELL
$73.44 - $82.41 $16,817 - $18,871
-229 Reduced 6.28%
3,418 $280,000
Q1 2019

May 01, 2019

BUY
$64.48 - $81.31 $28,306 - $35,695
439 Added 13.68%
3,647 $297,000
Q4 2018

Feb 13, 2019

BUY
$61.45 - $77.8 $21,937 - $27,774
357 Added 12.52%
3,208 $211,000
Q3 2018

Nov 20, 2018

SELL
$70.71 - $77.75 $2,192 - $2,410
-31 Reduced 1.08%
2,851 $219,000
Q2 2018

Aug 09, 2018

SELL
$63.43 - $75.41 $124,322 - $147,803
-1,960 Reduced 40.48%
2,882 $212,000
Q3 2017

Nov 08, 2017

BUY
$59.5 - $64.61 $90,737 - $98,530
1,525 Added 45.98%
4,842 $303,000
Q2 2017

Aug 14, 2017

BUY
N/A
3,317
3,317 $200,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Waldron Private Wealth LLC Portfolio

Follow Waldron Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waldron Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waldron Private Wealth LLC with notifications on news.